6571 |
SOLUTE CARRIER FAMILY 18 MEMBER A2 |
SLC18A2 |
SVAT |
SVMT |
VAT2 |
VMAT2 |
193001 |
10935 |
ENSG00000165646 |
OTTHUMG00000019121 |
Q05940 |
SYNAPTIC VESICULAR AMINE TRANSPORTER (MONOAMINE TRANSPORTER) (VESICULAR AMINE TRANSPORTER 2) (VAT2) (SOLUTE CARRIER FAMILY 18, MEMBER 2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q05940] |
VMAT2_HUMAN |
SOLUTE CARRIER FAMILY 18 MEMBER 2 |
SYNAPTIC VESICLE AMINE TRANSPORTER |
MONOAMINE TRANSPORTER |
Vesicular amine transporter 2 |
Synaptic vesicular amine transporter |
PA325 |
T48873 |
PKDYS2 |
Human Readable Name | DRUGGABLE GENOME |
Target Main Class | Transporters |
Target Subclass | SLC |
Transmembrane Helix Count | 12 |
Target Subclass | SLC18 |
Target Subclass | MFS |
Target Class | Transporters |
Target Subclass | TC:2.A.1.2.29 |
Gene Biotype | PROTEIN_CODING |
TRANSPORTER |
DRUGGABLE GENOME |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | tetrabenazine,Nitoman |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
n/a |
Novel drug target | Established target |
Trial Name | Lobeline |
n/a |
Trial Name | NBI-98854 |
Novel drug target | Established target |
inducer (activating) |
inhibitor (inhibitory) |
Trial Name | SLI 381, SPD 465,Adderall, Adderall XR, Adderall IR |
Novel drug target | Established target |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
Direct Interaction | yes |
Trial Name | - |
inhibitor (inhibitory) |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
Direct Interaction | yes |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
inhibitor (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
Direct Interaction | yes |
Trial Name | Vyvanse |
inhibitor (inhibitory) |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Synaptic vesicular amine transporter inhibitor |
Direct Interaction | yes |
SLC18A2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
SLC18A2 | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:2.A.1.2.29 |
ENSG00000165646 | Ensembl Gene Id |
6571 | Entrez Gene Id |
SLC18A2 | Gene Symbol |
Target Main Class | Transporters |
Target Subclass | SLC |
Transmembrane Helix Count | 12 |
SLC18A2 | Display Id |
SYNAPTIC VESICULAR AMINE TRANSPORTER (MONOAMINE TRANSPORTER) (VESICULAR AMINE TRANSPORTER 2) (VAT2) (SOLUTE CARRIER FAMILY 18, MEMBER 2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q05940] | Description |
ENSG00000165646 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
PA325 | PharmGKB ID |
ENSG00000165646 | Gene Symbol |
SLC18A2 | Ensembl Id |
DRUGGABLE GENOME |
VMAT2 | GENE_SYMBOL |
SLC18A2 | GENE_SYMBOL |
Synaptic vesicular amine transporter | UNIPROT |
SLC18A2 | TTD Gene Abbreviation |
T48873 | TTD Target ID |
Synaptic vesicular amine transporter | Gene Name |
Q05940 | UniProt ID |
TRANSPORTER |